Mitsubishi Tanabe Pharma America, Inc. will conduct a study to identify and measure specific biomarkers in people with amyotrophic lateral sclerosis (ALS).....
Ampersand Capital Partners has completed the acquisition of Pacific Biomarkers and merged it with existing portfolio company Neomed-Labs. This merger brings together two bioanalytical